One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion

PURPOSE: To report the 12-month efficacy and safety outcomes of intravitreal ziv-aflibercept in macular edema secondary to central retinal vein occlusion (CRVO). METHODS: Interventional case series documenting 12-month outcomes of intravitreal ziv-aflibercept (1.25 mg in 0.05 mL) in 6 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Eldeeb, Mohab, Chan, Errol W., Dedhia, Chintan J., Mansour, Ahmad, Chhablani, Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731707/
https://www.ncbi.nlm.nih.gov/pubmed/29260119
http://dx.doi.org/10.1016/j.ajoc.2017.10.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731707/
https://www.ncbi.nlm.nih.gov/pubmed/29260119
http://dx.doi.org/10.1016/j.ajoc.2017.10.011

Ejemplares similares